Sam, as always, thank you! Question- Would your normalized scripts account for this- "Cantor Fitzgerald analyst Louise Chen reiterated an Overweight rating and $35.00 price target on Amarin Corporation (NASDAQ: AMRN) noting that sales for Vascepa may be under represented by scripts. Apparently, an increasing percentage of scripts are coming in as 90-day scripts while 30-day and 90-day scripts are both counted as one. "
Thank you Sam. I think these numbers are quit good for a short week and you point about Friday is well taken. Good to see GL is still eating our dusk. Hope you have a great weekend.
Sam (and anyone else who remembers the answer) - I have same question as jjpow in post #201186 - don't normalized scrips take care of the 1 mo vs. 3 mo scrip or refill undercounting that used to exist? I think answer is definitely yes - because normalized scrips were 58,337 last week vs. old way of counting scrips where number was 45,304.